We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01416441
Recruitment Status : Completed
First Posted : August 15, 2011
Last Update Posted : April 15, 2015
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2014
  Study Completion Date : March 2014
  Certification or Request for Extension to Delay Results Submission: March 25, 2015